Background: Citalopram and escitalopram are commonly used serotonin-specific reuptake
inhibitors (SSRIs) for the treatment of depression and anxiety; which are known to cause …

AimsCitalopram and escitalopram are commonly used serotonin-specific reuptake inhibitors
(SSRIs) for the treatment of depression and anxiety. These medications are known to cause …

Abstract Background Although the US Food and Drug Administration (FDA) recommended
upper limits for citalopram dosing in older adults due to risk of corrected-QT (QTc) …

To achieve the objective of verifying whether there is a correlation between the use of
escitalopram in the elderly and QT prolongation, a search was carried out in Pubmed, Scielo …

Recently, Forest Laboratories warned about QTc prolongation associated with the use of
citalopram. After these reports, the FDA warned that citalopram should no longer be used at …

Background Some data suggests that citalopram has more risk of corrected QT interval
(QTc) prolongation than other selective serotonin reuptake inhibitors. Consequently the US …

Introduction: Recently, controversy has surrounded a 2011 Food and Drug Administration
warning against using citalopram at doses> 40 mg/day due to QTc prolonging effects …

IntroductionIn 2011, the FDA issued an alert recommending not to prescribe citalopram high
doses, due to QT prolongation risk. We explored the clinical background of QT interval …

Background For a decade, patients have been advised against using high citalopram-and
escitalopram-doses due to risk for ventricular arrhythmia and cardiac arrest. Still, these …

The selective serotonin reuptake inhibitors (SSRIs) citalopram and escitalopram are
associated with QT prolongation, which increases the risk of serious arrhythmia …